BCR and acute myeloid leukemia: Since ALL, AML (in some cases) and chronic myeloid leukemia (CML) (through BCR-ABL) are also MYC-positive, we tested whether HSP90 inhibition would downregulate MYC in the human CML cell line, K562 (Supplementary Figure S3).